Coarse-grained models for protein aggregation

Current Opinion in Structural Biology

Volumn 21, Issue 2, 2011, Pages 209-220

  Wu, Chun ^a   Shea, Joan Emma ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA SHEET; COARSE GRAINED MODEL; HUMAN; HYDROPHOBICITY; MODEL; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MONTE CARLO METHOD; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION; REVIEW; STRUCTURAL PROTEOMICS;

COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEINS;

EID: 79953081933     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2011.02.002     Document Type: Review

References (126)

1. Selkoe D.J. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 2004, 6:1054-1061.
2. Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006, 75:333-366.
3. Fandrich M., Forge V., Buder K., Kittler M., Dobson C.M., Diekmann S. Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. Proc Natl Acad Sci U S A 2003, 100:15463-15468.
4. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002, 416:507-511.
5. Fowler D.M., Koulov A.V., Balch W.E., Kelly J.W. Functional amyloid-from bacteria to humans. Trends Biochem Sci 2007, 32:217-224.
6. Zhang S. Fabrication of novel biomaterials through molecular self-assembly. Nat Biotechnol 2003, 21:1171-1178.
7. Sunde M., Blake C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv Protein Chem 1997, 50:123-159.
8. Luhrs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., Doeli H., Schubert D., Riek R. 3D structure of Alzheimer's amyloid-β(1-42) fibrils. Proc Natl Acad Sci U S A 2005, 102:17342-17347.
9. Petkova A.T., Ishii Y., Balbach J.J., Antzutkin O.N., Leapman R.D., Delaglio F., Tycko R. A structural model for Alzheimer's Abeta-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci U S A 2002, 99:16742-16747.
10. Luca S., Yau W.M., Leapman R., Tycko R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry (Mosc) 2007, 46:13505-13522.
11. Serpell L.C., Sunde M., Benson M.D., Tennent G.A., Pepys M.B., Fraser P.E. The protofilament substructure of amyloid fibrils. J Mol Biol 2000, 300:1033-1039.
12. Serpell L.C., Sunde M., Blake C.C.F. The molecular basis of amyloidosis. Cell Mol Life Sci 1997, 53:871-887.
13. Sunde M., Serpell L.C., Bartlam M., Fraser P.E., Pepys M.B., Blake C.C.F. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol 1997, 273:729-739.
14. Tycko R. Molecular structure of amyloid fibrils: insights from solid-state NMR. Q Rev Biophys 2006, 39:1-55.
15. Harper J.D., Lansbury P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 1997, 66:385-407.
16. Padrick S.B., Miranker A.D. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry (Mosc) 2002, 41:4694-4703.
17. Lambert M.P. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 1998, 95:6448-6453.
18. Walsh D.M., Lomakin A., Benedek G.B., Condron M.M., Teplow D.B. Amyloid β-protein fibrillogenesis-detection of a protofibrillar intermediate. J Biol Chem 1997, 272:22364-22372.
19. Shankar G.M., Li S.M., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008, 14:837-842.
20. Carulla Nl., Zhou M., Arimon M., Gairi M., Giralt E., Robinson C.V., Dobson C.M. Experimental characterization of disordered and ordered aggregates populated during the process of amyloid fibril formation. Proc Natl Acad Sci U S A 2009, 106:7828-7833.
21. Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid Aβ-peptide. Nat Rev Mol Cell Biol 2007, 8:101-112.
22. Goldsbury C., Kistler J., Aebi U., Arvinte T., Cooper G.J.S. Watching amyloid fibrils grow by time-lapse atomic force microscopy. J Mol Biol 1999, 285:33-39.
23. Marek P., Abedini A., Song B.B., Kanungo M., Johnson M.E., Gupta R., Zaman W., Wong S.S., Raleigh D.P. Aromatic interactions are not required for amyloid fibril formation by islet amyloid polypeptide but do influence the rate of fibril formation and fibril morphology. Biochemistry (Mosc) 2007, 46:3255-3261.
24. Kayed R., Bernhagen J., Greenfield N., Sweimeh K., Brunner H., Voelter W., Kapurniotu A. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J Mol Biol 1999, 287:781-796.
25. Abedini A., Raleigh D.P. A role for helical intermediates in amyloid formation by natively unfolded polypeptides?. Phys Biol 2009, 6:015005.
26. Williamson J.A., Miranker A.D. Direct detection of transient α-helical states in islet amyloid polypeptide. Protein Sci 2007, 16:110-117.
27. Shim S.H., Gupta R., Ling Y.L., Strasfeld D.B., Raleigh D.P., Zanni M.T. Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution. Proc Natl Acad Sci U S A 2009, 106:6614-6619.
28. Bernstein S.L., Dupuis N.F., Lazo N.D., Wyttenbach T., Condron M.M., Bitan G., Teplow D.B., Shea J.-E., Ruotolo B.T., Robinson C.V., et al. Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. Nat Chem 2009, 1:326-331.
29. Dupuis N.F., Wu C., Shea J.-E., Bowers M.T. Human islet amyloid polypeptide monomers form ordered β-hairpins: a possible direct amyloidogenic precursor. J Am Chem Soc 2009, 191:18283-18292.
30. Baumketner A., Bernstein S.L., Wyttenbach T., Bitan G., Teplow D.B., Bowers M.T., Shea J.-E. Amyloid β-protein monomer structure: a computational and experimental study. Protein Sci 2006, 15:420-428.
31. Thirumalai D., Klimov D.K., Dima R.I. Emerging ideas on the molecular basis of protein and peptide aggregation. Curr Opin Struct Biol 2003, 13:146-159.
32. Tarus B., Straub J.E., Thirumalai D. Dynamics of Asp23-Lys28 salt-bridge formation in Aβ10-35 monomers. J Am Chem Soc 2006, 128:16159-16168.
33. Nam H.B., Kouza M., Zung H., Li M.S. Relationship between population of the fibril-prone conformation in the monomeric state and oligomer formation times of peptides: insights from all-atom simulations. J Chem Phys 2010, 132:165104-165110.
34. Straub J.E., Thirumalai D. Principles governing oligomer formation in amyloidogenic peptides. Curr Opin Struct Biol 2010, 20:187-195.
35. Ma B., Nussinov R. Simulations as analytical tools to understand protein aggregation and predict amyloid conformation. Curr Opin Chem Biol 2006, 10:445-452.
36. Jang S., Shin S. Computational study on the structural diversity of amyloid β peptide (Aβ(10-35)) oligomers. J Phys Chem B 2008, 112:3479-3484.
37. Masman M.F., Eisel U.L.M., Csizmadia I.G., Penke B., Enriz R.D., Marrink S.J., Luiten P.G.M. In silico study of full-length amyloid β (1-42) tri- and penta-oligomers in solution. J Phys Chem B 2009, 113:11710-11719.
38. Reddy G., Straub J.E., Thirumalai D. Influence of preformed Asp23-Lys28 salt bridge on the conformational fluctuations of monomers and dimers of Aβ peptides with implications for rates of fibril formation. J Phys Chem B 2009, 113:1162-1172.
39. Sgourakis N.G., Yan Y., McCallum S.A., Wang C., Garcia A.E. The Alzheimer's peptides Aβ40 and 42 adopt distinct conformations in water: a combined MD/NMR study. J Mol Biol 2007, 368:1448-1457.
40. Tarus B., Straub J.E., Thirumalai D. Probing the initial stage of aggregation of the Aβ10-35 protein: assessing the propensity for peptide dimerization. J Mol Biol 2005, 345:1141-1156.
41. Miller Y., Ma B., Nussinov R. Polymorphism of Alzheimer's Aβ17-42(p3) oligomers: the importance of the turn location and its conformation. Biophys J 2009, 97:1168-1177.
42. Wu C., Bowers M.T., Shea J.-E. Molecular structures of quiescently-grown and brain-derived polymorphic fibrils of the Alzheimer amyloid Aβ 9-40 peptide: a comparison to agitated fibrils. PLoS Comp Biol 2010, 6:e1000693.
43. Buchete N.V., Hummer G. Structure and dynamics of parallel β-sheets, hydrophobic core, and loops in Alzheimer's Aβ fibrils. Biophys J 2007, 92:3032-3039.
44. Patro S.Y., Przybycien T.M. Simulations of reversible protein aggregate and crystal structure. Biophys J 1996, 70:2888-2902.
45. Zhang J., Muthukumar M. Simulations of nucleation and elongation of amyloid fibrils. J Chem Phys 2009, 130:035102.
46. Dima R.I., Thirumalai D. Exploring protein aggregation and self-propagation using lattice models: phase diagram and kinetics. Protein Sci 2002, 11:1036-1049.
47. Li M.S., Klimov D.K., Straub J.E., Thirumalai D. Probing the mechanisms of fibril formation using lattice models. J Chem Phys 2008, 129:175101.
48. Cellmer T., Bratko D., Prausnitz J.M., Blanch H. Protein-folding landscapes in multichain systems. Proc Natl Acad Sci U S A 2005, 102:11692-11697.
49. Fawzi N.L., Okabe Y., Yap E.-H., Head-Gordon T. Determining the critical nucleus and mechanism of fibril elongation of the Alzheimer's Aβ1-40 peptide. J Mol Biol 2007, 365:535-550.
50. Li M.S., Co N.T., Reddy G., Hu C.-K., Straub J.E., Thirumalai D. Factors governing fibrillogenesis of polypeptide chains revealed by lattice models. Phys Rev Lett 2010, 105:218101.
51. Garai K., Sahoo B., Sengupta P., Maiti S. Quasihomogeneous nucleation of amyloid β yields numerical bounds for the critical radius, the surface tension, and the free energy barrier for nucleus formation. J Chem Phys 2008, 128:045102.
52. Bellesia G., Shea J.-E. Self-assembly of β-sheet forming peptides into chiral fibrillar aggregates. J Chem Phys 2007, 126:245104.
53. Bellesia G., Shea J.-E. Diversity of kinetic pathways in amyloid fibril formation. J Chem Phys 2009, 131:111102.
54. Bellesia G., Shea J.-E. Effect of β-sheet propensity on peptide aggregation. J Chem Phys 2009, 130:145103.
55. Friedman R., Pellarin R., Caflisch A. Soluble protofibrils as metastable intermediates in simulations of amyloid fibril degradation induced by lipid vesicles. J Phys Chem Lett 2010, 1:471-474.
56. Friedman R., Pellarin R., Caflisch A. Amyloid aggregation on lipid bilayers and its impact on membrane permeability. J Mol Biol 2009, 387:407-415.
57. Magno A., Caflisch A., Pellarin R. Crowding effects on amyloid aggregation kinetics. J Phys Chem Lett 2010, 1:3027-3032.
58. Pellarin R., Caflisch A. Interpreting the aggregation kinetics of amyloid peptides. J Mol Biol 2006, 360:882-892.
59. Pellarin R., Guarnera E., Caflisch A. Pathways and intermediates of amyloid fibril formation. J Mol Biol 2007, 374:917-924.
60. Pellarin R., Schuetz P., Guarnera E., Caflisch A. Amyloid fibril polymorphism is under kinetic control. J Am Chem Soc 2010, 132:14960-14970.
61. Auer S., Dobson C.M., Vendruscolo M., Maritan A. Self-templated nucleation in peptide and protein aggregation. Phys Rev Lett 2008, 101:258101.
62. Auer S., Meersman F., Dobson C.M., Vendruscolo M. A generic mechanism of emergence of amyloid protofilaments from disordered oligomeric aggregates. PLoS Comp Biol 2008, 4:e1000222.
63. Auer S., Trovato A., Vendruscolo M. A condensation-ordering mechanism in nanoparticle-catalyzed peptide aggregation. PLoS Comp Biol 2009, 5:e1000458.
64. Auer S., Kashchiev D. Phase diagram of α-helical and β-sheet forming peptides. Phys Rev Lett 2010, 104:168105.
65. Urbanc B., Betnel M., Cruz L., Bitan G., Teplow D.B. Elucidation of amyloid β-protein oligomerization mechanisms: discrete molecular dynamics study. J Am Chem Soc 2010, 132:4266-4280.
66. Gobbi M., Colombo L., Morbin M., Mazzoleni G., Accardo E., Vanoni M., Del Favero E., Cantu L., Kirschner D.A., Manzoni C., et al. Gerstmann-Straeussler-Scheinker disease amyloid protein polymerizes according to the 'dock-and-lock' model. J Biol Chem 2006, 281:843-849.
67. Nguyen H.D., Hall C.K. Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc Natl Acad Sci U S A 2004, 101:16180-16185.
68. Urbanc B., Cruz L., Ding F., Sammond D., Khare S., Buldyrev S.V., Stanley H.E., Dokholyan N.V. Molecular dynamics simulation of amyloid β dimer formation. Biophys J 2004, 87:2310-2321.
69. Dima R.I., Settanni G., Micheletti C., Banavar J.R., Maritan A. Extraction of interaction potentials between amino acids from native protein structures. J Chem Phys 2000, 112:9151-9166.
70. Heo M., Kim S., Moon E.J., Cheon M., Chung K., Chang I. Perceptron learning of pairwise contact energies for proteins incorporating the amino acid environment. Phys Rev E 2005, 72:1-9.
71. Jernigan R.L., Bahar I. Structure-derived potentials and protein simulations. Curr Opin Struct Biol 1996, 6:195-209.
72. Meller J., Wagner M., Elber R. Maximum feasibility guideline in the design and analysis of protein folding potentials. J Comput Chem 2002, 23:111-118.
73. Mirny L.A., Shakhnovich E.I. How to derive a protein folding potential? A new approach to an old problem. J Mol Biol 1996, 264:1164-1179.
74. Park B., Levitt M. Energy functions that discriminate X-ray and near-native folds from well-constructed decoys. J Mol Biol 1996, 258:367-392.
75. Sippl M.J. Knowledge-based potentials for proteins. Curr Opin Struct Biol 1995, 5:229-235.
76. Thomas P.D., Dill K.A. An iterative method for extracting energy-like quantities from protein structures. Proc Natl Acad Sci U S A 1996, 93:11628-11633.
77. Bellesia G., Jewett A.I., Shea J.-E. Sequence periodicity and secondary structure propensity in model proteins. Protein Sci 2010, 19:141-154.
78. Lomakin A., Chung D.S., Benedek G.B., Kirschner D.A., Teplow D.B. On the nucleation and growth of amyloid Aβ protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci U S A 1996, 93:1125-1129.
79. Chen S.M., Ferrone F.A., Wetzel R. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci U S A 2002, 99:11884-11889.
80. Liang Y., Lynn D.G., Berland K.M. Direct observation of nucleation and growth in amyloid self-assembly. J Am Chem Soc 2010, 132:6306-6308.
81. Kashchiev D., Auer S. Nucleation of amyloid fibrils. J Chem Phys 2010, 132:215101.
82. Auer S., Dobson C.M., Vendruscolo M. Characterization of the nucleation barriers for protein aggregation and amyloid formation. Hfsp J 2007, 1:137-146.
83. Serio T.R., Cashikar A.G., Kowal A.S., Sawicki G.J., Moslehi J.J., Serpell L., Arnsdorf M.F., Lindquist S.L. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 2000, 289:1317-1321.
84. Cheon M., Chang I., Hall C.K. Extending the PRIME model for protein aggregation to all 20 amino acids. Proteins Struct Funct Bioinf 2010, 78:2950-2960.
85. Nguyen H.D., Hall C.K. Spontaneous fibril formation by polyalanines; discontinuous molecular dynamics simulations. J Am Chem Soc 2006, 128:1890-1901.
86. Urbanc B., Cruz L., Yun S., Buldyrev S.V., Bitan G., Teplow D.B., Stanley H.E. In silico study of amyloid β-protein folding and oligomerization. Proc Natl Acad Sci U S A 2004, 101:17345-17350.
87. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G.B., Teplow D.B. Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A 2003, 100:330-335.
88. Melchor J.P., McVoy L., Van Nostrand W.E. Charge alterations of E22 enhance the pathogenic properties of the amyloid β-protein. J Neurochem 2000, 74:2209-2212.
89. Van Nostrand W.E., Melchor J.P., Cho H.S., Greenberg S.M., Rebeck G.W. Pathogenic effects of D23N Iowa mutant amyloid β-protein. J Biol Chem 2001, 276:32860-32866.
90. Crescenzi O., Tomaselli S., Guerrini R., Salvadori S., D'Ursi A.M., Temussi P.A., Picone D. Solution structure of the Alzheimer amyloid β-peptide (1-42) in an apolar microenvironment-similarity with a virus fusion domain. Eur J Biochem 2002, 269:5642-5648.
91. Eakin C.M., Attenello F.J., Morgan C.J., Miranker A.D. Oligomeric assembly of native-like precursors precedes amyloid formation by β2 microglobulin. Biochemistry (Mosc) 2004, 43:7808-7815.
92. Teplow D.B., Lazo N.D., Bitan G., Bernstein S., Wyttenbach T., Bowers M.T., Baumketner A., Shea J.-E., Urbanc B., Cruz L., et al. Elucidating amyloid β-protein folding and assembly: a multidisciplinary approach. Acc Chem Res 2006, 39:635-645.
93. Gazit E. Self-assembled peptide nanostructures: the design of molecular building blocks and their technological utilization. Chem Soc Rev 2007, 36:1263-1269.
94. Tjernberg L., Hosia W., Bark N., Thyberg J., Johansson J. Charge attraction and β propensity are necessary for amyloid fibril formation from tetrapeptides. J Biol Chem 2002, 277:43243-43246.
95. Balbirnie M., Grothe R., Eisenberg D.S. An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated β-sheet structure for amyloid. Proc Natl Acad Sci U S A 2001, 98:2375-2380.
96. Baumketner A., Shea J.E. Free energy landscapes for amyloidogenic tetrapeptides dimerization. Biophys J 2005, 89:1493-1503.
97. Bellesia G., Shea J.-E. What determines the structure and stability of KFFE monomers, dimers, and protofibrils?. Biophys J 2009, 96:875-886.
98. Reddy A.S., Wang L., Lin Y.S., Ling Y., Chopra M., Zanni M.T., Skinner J.L., De Pablo J.J. Solution structures of rat amylin peptide: simulation, theory, and experiment. Biophys J 2010, 98:443-451.
99. Reddy A.S., Wang L., Singh S., Ling Y., Buchanan L., Zanni M.T., Skinner J.L., De Pablo J.J. Stable and metastable states of human amylin in solution. Biophys J 2010, 99:2208-2216.
100. Nilsberth C., Westlind-Danielsson A., Eckman C.B., Condron M.M., Axelman K., Forsell C., Stenh C., Luthman J., Teplow D.B., Younkin S.G., et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat Neurosci 2001, 4:887-893.
101. Lashuel H.A. Mixtures of wild-type and a pathogenic (E22G) form of Aβ40 in vitro accumulate protofibrils, including amyloid pores. J Mol Biol 2003, 332:795-808.
102. Teplow D.B. Structural and kinetic features of amyloid β-protein fibrillogenesis. Amyloid J Protein Fold Disord 1998, 5:121-142.
103. Williams A.D., Sega M., Chen M.L., Kheterpal I., Geva M., Berthelier V., Kaleta D.T., Cook K.D., Wetzel R. Structural properties of Aβ protofibrils stabilized by a small molecule. Proc Natl Acad Sci U S A 2005, 102:7115-7120.
104. Kheterpal I., Chen M., Cook K.D., Wetzel R. Structural differences in Aβ amyloid protofibrils and fibrils mapped by hydrogen exchange-mass spectrometry with on-line proteolytic fragmentation. J Mol Biol 2006, 361:785-795.
105. Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Assembly of β-amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry (Mosc) 1999, 38:8972-8980.
106. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Condron M.M., Lomakin A., Benedek G.B., Selkoe D.J., Teplow D.B. Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 1999, 274:25945-25952.
107. Nichols M.R., Moss M.A., Reed D.K., Lin W.-L., Mukhopadhyay R., Hoh J.H., Rosenberry T.L. Growth of β-Amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. Biochemistry (Mosc) 2002, 41:6115-6127.
108. Yagi H., Ban T., Morigaki K., Naiki H., Goto Y. Visualization and classification of amyloid β supramolecular assemblies. Biochemistry (Mosc) 2007, 46:15009-15017.
109. Massi F., Straub J.E. Energy landscape theory for Alzheimer's amyloid β-peptide fibril elongation. Proteins Struct Funct Genet 2001, 42:217-229.
110. Straub J.E., Thirumalai D. Towards a molecular theory of early and late events in monomer to amyloid fibril. Annu Rev Phys Chem 2011, 62:437-463.
111. Tarus B., Straub J.E., Thirumalai D. Probing the initial stage of aggregation of the Aβ(10-35)-protein: Assessing the propensity for peptide dimerization. J Mol Biol 2005, 345:1141-1156.
112. Esler W.P., Stimson E.R., Ghilardi J.R., Lu Y.A., Felix A.M., Vinters H.V., Mantyh P.W., Lee J.P., Maggio J.E. Point substitution in the central hydrophobic cluster of a human β-amyloid congener disrupts peptide folding and abolishes plaque competence. Biochemistry (Mosc) 1996, 35:13914-13921.
113. Esler W.P., Stimson E.R., Jennings J.M., Vinters H.V., Ghilardi J.R., Lee J.P., Mantyh P.W., Maggio J.E. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry (Mosc) 2000, 39:6288-6295.
114. Green J.D., Goldsbury C., Kistler J., Cooper G.J.S., Aebi U. Human Amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation. J Biol Chem 2004, 279:12206-12212.
115. Sciarretta K.L., Gordon D.J., Petkova A.T., Tycko R., Meredith S.C. Aβ40-lactam (D23/K28) models a conformation highly favorable for nucleation of amyloid. Biochemistry (Mosc) 2005, 44:6003-6014.
116. Paravastu A.K., Qahwash I., Leapman R.D., Meredith S.C., Tycko R. Seeded growth of β-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc Natl Acad Sci U S A 2009, 106:7443-7448.
117. Knight J.D., Miranker A.D. Phospholipid catalysis of diabetic amyloid assembly. J Mol Biol 2004, 341:1175-1187.
118. Choo-Smith L.-P.Ä., Garzon-Rodriguez W., Glabe C.G., Surewicz W.K. Acceleration of amyloid fibril formation by specific binding of Aβ(1-40) peptide to ganglioside-containing membrane vesicles. J Biol Chem 1997, 272:22987-22990.
119. Jang H., Arce F.T., Ramachandran S., Capone R., Azimova R., Kagan B.L., Nussinov R., Lal R. Truncated β-amyloid peptide channels provide an alternative mechanism for Alzheimer's disease and Down syndrome. Proc Natl Acad Sci U S A 2010, 107:6538-6543.
120. Arispe N. Architecture of the Alzheimer's AßP ion channel pore. J Membr Biol 2004, 197:33-48.
121. Ambroggio E.E., Kim D.H., Separovic F., Barrow C.J., Barnham K.J., Bagatolli L.A., Fidelio G.D. Surface behavior and lipid interaction of Alzheimer β-amyloid peptide 1-42: a membrane-disrupting peptide. Biophys J 2005, 88:2706-2713.
122. Stefani M. Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity. FEBS J 2010, 277:4602-4613.
123. Brannigan G., Philips P.F., Brown F.L.H. Flexible lipid bilayers in implicit solvent. Phys Rev E 2005, 72:011915.
124. Cooke I.R., Deserno M. Solvent-free model for self-assembling fluid bilayer membranes: stabilization of the fluid phase based on broad attractive tail potentials. J Chem Phys 2005, 123:224710.
125. Wei G.H., Song W., Derreumaux P., Mousseau N. Self-assembly of amyloid-forming peptides by molecular dynamics simulations. Front Biosci 2008, 13:5681-5692.
126. Irback A., Mohanty S. PROFASI: a Monte Carlo simulation package for protein folding and aggregation. J Comput Chem 2006, 27:1548-1555.